Empowering Biotechnology Through Molecular Intelligence
The analysis of molecules represents most of the workload in clinical labs and is key to early disease diagnosis. However, current databases only cover a small fraction of known molecules, whichlead s to a high percentage of ambiguous results.
By using the vibrations of a molecule as a unique fingerprint, Isospec can conclusively assign a molecule’s structure via a proprietary database that the EPFL-spinoff develops.
This enables the discovery of new disease biomarkers, accelerates the development of therapeutics, and transforms the future of clinical nutrition.